However, studies conducted in prostate cancer patients [3,4] have revealed that 30% of patients harboring a germline mutation in a DDR gene and 15% of those who carry a BRCA2 mutation do not have a relative affected by cancer. The gene discussed is BRCA2; the disease is prostate carcinoma.